Is Covid19 testing the Liver Cancer Screening Market? Leading Players: Illumina, Inc., Thermo Fisher Scientific Inc., Abbott, Danaher, Siemens Healthcare GmbH, Hoffmann-La Roche Ltd, Sysmex Corporation, Biocept, Inc., Foundation Medicine, Inc

An Overview of the Impact of COVID-19 on Liver Cancer Screening Market:

The emergence of COVID-19 has brought the world to a standstill. We understand that this health crisis has brought an unprecedented impact on businesses across industries. However, this too shall pass. Rising support from governments and several companies can help in the fight against this highly contagious disease. There are some industries that are struggling and some are thriving. Overall, almost every sector is anticipated to be impacted by the pandemic.

We are taking continuous efforts to help your business sustain and grow during COVID-19 pandemics. Based on our experience and expertise, we will offer you an impact analysis of coronavirus outbreak across industries to help you prepare for the future.

Liver Cancer Screening Market Size, Share and Global Trend By Type (Hepatocellular Carcinoma, Cholangiocarcinoma, Hepatoblastoma), By Screening (Laboratory Testing, Imaging, Endoscopy, Biopsy), By End User (Hospitals, Oncology Clinics, Diagnostics Centers) and Geography Forecast till 2026.

Request a sample copy of the report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/liver-cancer-screening-market-101175

Leading Players: Illumina, Inc., Thermo Fisher Scientific Inc., Abbott, Danaher, Siemens Healthcare GmbH, Hoffmann-La Roche Ltd, Sysmex Corporation, Biocept, Inc., Foundation Medicine, Inc.

Market Highlights:

The American Society for Clinical Oncology (ASCO) states that approximately 42,220 adults were suffering from primary liver cancer in the U.S. Out of those, an estimated 30,610 were men and 11,610 were women. ASCO further declared that since 1980, the rates of liver cancer have tripled. This information is published in an upcoming report by Fortune Business Insights, titled, "Liver Cancer Screening Market Size, Share and Global Trend By Type (Hepatocellular Carcinoma, Cholangiocarcinoma, Hepatoblastoma), By Screening (Laboratory Testing, Imaging, Endoscopy, Biopsy), By End User (Hospitals, Oncology Clinics, Diagnostics Centers) and Geography Forecast till 2026." The report provides elaborate data regarding the global liver cancer screening market segmentation, followed by market share. Additionally, the report offers details about the latest developments happening in the industry. It further showcases in-depth information about the ongoing trends and regional analysis.

Rise in Demand for Preventive Care for Diagnostic Examinations to Favor Growth in North America

The global liver cancer screening market is geographically divided into the Middle East and Africa, North America, Asia Pacific, Europe, and Latin America. Amongst these, North America is in the dominant position and it currently holds the highest global cancer screening market share. The growth is attributed to the rising incidence of liver cancer, increasing demand for preventive care by diagnostic examinations, and high healthcare expenditure. Additionally, increasing awareness programs regarding liver cancer, easy access to advanced treatment options, increasing investments by key market players for the development of early diagnostic options, and well-established healthcare infrastructure are likely to fuel the liver cancer screening market growth in this region.

Asia Pacific, on the other hand, is considered to be one of the fastest growing markets due to a rise in the prevalence of cancer. Moreover, expansion of healthcare infrastructure, greater disposable income, increasing demand for technologically advanced diagnostics, and high patient pool are expected to boost liver cancer screening market growth in this region.

Epigenomics and Oncimmune Aim to Increase Sales through Technologically Advanced Product Launches

The Johns Hopkins University of Johns Hopkins Health System Corporation announced that it received the biggest A Series investment for CancerSEEK in June 2019. CancerSEEK is a liquid biopsy test that is specially designed for detecting various cancer types at the initial stages of the disease. Thrive Earlier Detection Corp., a developer of cancer detecting tests, based in Cambridge, is currently developing CancerSEEK with the help of $110 million funding. According to the company, CancerSEEK will be a blood-based test that would be cost-effective and would be used as part of regular medical care. The test will serve as a resource to support those patients and their families who are often confused and overwhelmed following a cancer diagnosis.

Epigenomics AG, a molecular diagnostics company, based in Berlin, announced the launch of its blood test called mSEPT9 in July 2018. In a clinical study, mSEPT9 exhibited more diagnostic accuracy than the already established diagnostic marker. It also surpassed alpha-fetoprotein (AFP), a widely used diagnostic marker. According to the company, an accurate blood test will have the capacity to monitor those patients who are at high risk for suffering from liver cancer.

Liver Cancer Screening Market 2020 global industry research report is a professional and in-depth study on the Liver Cancer Screening Market trends, share, size, growth, as well as industry analysis. Development policies and plans are discussed as well as manufacturing processes and cost structures are also analyzed. This report also states import/export consumption, supply and demand Figures, cost, price, revenue and gross margins. The report also focuses on global major leading industry players of Global Liver Cancer Screening Market providing information such as company profiles, product picture and specification, capacity, cost, production, price, revenue and contact information. Upstream raw materials and equipment and downstream demand analysis is also carried out. Liver Cancer Screening Market Forecast 2025 report study provides key statistics on the market status of the Liver Cancer Screening Market manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry.

Liver Cancer Screening Market report also include data type such as capacity, production, market share, price, growth rate, consumption, import, export etc. Industry chain, manufacturing process, cost structure, marketing channel are also analysed in this report.

Market Segment by Regional Analysis covers:

North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
The global Liver Cancer Screening Market is anticipated to rise at a considerable rate during the forecast period, between 2020 and 2024. In 2020, the market was growing at a steady rate and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.

Table of Contents

1 Market Overview

1.1 Liver Cancer Screening Market Introduction

1.2 Market Analysis by Type

1.3 Market Analysis by Applications

1.4 Market Analysis by Regions

1.4.1 North America (United States, Canada and Mexico)

1.4.2 Europe (Germany, France, UK, Russia and Italy)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

1.4.4 South America, Middle East and Africa

1.5 Market Dynamics

Click here to get the short-term and long-term impact of COVID-19 on this Liver Cancer Screening Market: https://www.fortunebusinessinsights.com/industry-reports/liver-cancer-screening-market-101175

About us:

Fortune Business Insights offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

Contact Us:

Fortune Business Insights Pvt. Ltd.

Supreme Headquarters,

Pune Banglore Highway, Baner, Pune,

Maharashtra 411045, India

US: +1 424 253 0390

UK: +44 2071 939123

APAC: +91 744 740 1245

Email: sales@fortunebusinessinsights.com

Pune Banglore Highway Pashan Exit, Baner, Pune, Maharashtra 411045, India

Fortune Business Insights offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

This release was published on openPR.